ID   UBP6_HUMAN              Reviewed;        1406 AA.
AC   P35125; Q15634; Q86WP6; Q8IWT4;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 2.
DT   15-MAR-2017, entry version 145.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 6;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 6;
DE   AltName: Full=Proto-oncogene TRE-2;
DE   AltName: Full=Ubiquitin thioesterase 6;
DE   AltName: Full=Ubiquitin-specific-processing protease 6;
GN   Name=USP6; Synonyms=HRP1, TRE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), TISSUE SPECIFICITY, AND
RP   VARIANTS ARG-475 AND GLN-912.
RC   TISSUE=Ewing sarcoma;
RX   PubMed=1565468;
RA   Nakamura T., Hillova J., Mariage-Samson R., Onno M., Huebner K.,
RA   Cannizzaro L.A., Boghosian-Sell L., Croce C.M., Hill M.;
RT   "A novel transcriptional unit of the tre oncogene widely expressed in
RT   human cancer cells.";
RL   Oncogene 7:733-741(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), ALTERNATIVE
RP   SPLICING, TISSUE SPECIFICITY, AND DISCUSSION OF TRE2 EVOLUTION.
RX   PubMed=12604796; DOI=10.1073/pnas.0437015100;
RA   Paulding C.A., Ruvolo M., Haber D.A.;
RT   "The Tre2 (USP6) oncogene is a hominoid-specific gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:2507-2511(2003).
RN   [3]
RP   CHARACTERIZATION.
RX   PubMed=8247125; DOI=10.1038/366313a0;
RA   Papa F.R., Hochstrasser M.;
RT   "The yeast DOA4 gene encodes a deubiquitinating enzyme related to a
RT   product of the human tre-2 oncogene.";
RL   Nature 366:313-319(1993).
RN   [4]
RP   MUTAGENESIS OF THR-150 AND ARG-187.
RX   PubMed=14521938; DOI=10.1016/j.bbrc.2003.09.051;
RA   Bizimungu C., De Neve N., Burny A., Bach S., Bontemps F.,
RA   Portetelle D., Vandenbol M.;
RT   "Expression in a RabGAP yeast mutant of two human homologues, one of
RT   which is an oncogene.";
RL   Biochem. Biophys. Res. Commun. 310:498-504(2003).
RN   [5]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH RAC1 AND CDC42.
RX   PubMed=12612085; DOI=10.1128/MCB.23.6.2151-2161.2003;
RA   Masuda-Robens J.M., Kutney S.N., Qi H., Chou M.M.;
RT   "The TRE17 oncogene encodes a component of a novel effector pathway
RT   for Rho GTPases Cdc42 and Rac1 and stimulates actin remodeling.";
RL   Mol. Cell. Biol. 23:2151-2161(2003).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH CDH11.
RX   PubMed=15026324; DOI=10.1158/0008-5472.CAN-03-2827;
RA   Oliveira A.M., Hsi B.L., Weremowicz S., Rosenberg A.E., Dal Cin P.,
RA   Joseph N., Bridge J.A., Perez-Atayde A.R., Fletcher J.A.;
RT   "USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst.";
RL   Cancer Res. 64:1920-1923(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH ARF6.
RX   PubMed=15509780; DOI=10.1128/MCB.24.22.9752-9762.2004;
RA   Martinu L., Masuda-Robens J.M., Robertson S.E., Santy L.C.,
RA   Casanova J.E., Chou M.M.;
RT   "The TBC (Tre-2/Bub2/Cdc16) domain protein TRE17 regulates plasma
RT   membrane-endosomal trafficking through activation of Arf6.";
RL   Mol. Cell. Biol. 24:9752-9762(2004).
RN   [8]
RP   FUNCTION, INTERACTION WITH CALMODULIN, UBIQUITINATION, AND MUTAGENESIS
RP   OF CYS-541.
RX   PubMed=16127172; DOI=10.1074/jbc.M505220200;
RA   Shen C., Ye Y., Robertson S.E., Lau A.W., Mak D.O., Chou M.M.;
RT   "Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific
RT   protease TRE17/USP6.";
RL   J. Biol. Chem. 280:35967-35973(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=20418905; DOI=10.1038/onc.2010.116;
RA   Ye Y., Pringle L.M., Lau A.W., Riquelme D.N., Wang H., Jiang T.,
RA   Lev D., Welman A., Blobel G.A., Oliveira A.M., Chou M.M.;
RT   "TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces
RT   matrix metalloproteinase production via activation of NF-kappaB.";
RL   Oncogene 29:3619-3629(2010).
CC   -!- FUNCTION: Deubiquitinase with an ATP-independent isopeptidase
CC       activity, cleaving at the C-terminus of the ubiquitin moiety.
CC       Catalyzes its own deubiquitination. In vitro, isoform 2, but not
CC       isoform 3, shows deubiquitinating activity. Promotes plasma
CC       membrane localization of ARF6 and selectively regulates ARF6-
CC       dependent endocytic protein trafficking. Is able to initiate
CC       tumorigenesis by inducing the production of matrix
CC       metalloproteinases following NF-kappa-B activation.
CC       {ECO:0000269|PubMed:15509780, ECO:0000269|PubMed:16127172,
CC       ECO:0000269|PubMed:20418905}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Interacts with RAC1 and CDC42. Interacts (via Rab-GAP TBC
CC       domain) with ARF6. Interacts with calmodulin (CALM1, CALM2 and/or
CC       CALM3); the interaction is calcium-dependent.
CC       {ECO:0000269|PubMed:12612085, ECO:0000269|PubMed:15509780,
CC       ECO:0000269|PubMed:16127172}.
CC   -!- INTERACTION:
CC       Q8N8A2:ANKRD44; NbExp=4; IntAct=EBI-954590, EBI-1245329;
CC       P10916:MYL2; NbExp=5; IntAct=EBI-954590, EBI-725770;
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Cytoplasm. Endosome.
CC       Note=Localizes to the plasma membrane and to filamentous
CC       structures within the cell corresponding to ARF6 regulated tubular
CC       endosomes. Activation of RAC1 and CDC42 can direct the
CC       relocalization of USP6 to the plasma membrane in a manner that
CC       depends on the integrity of the actin cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P35125-1; Sequence=Displayed;
CC       Name=2; Synonyms=213(ORF2);
CC         IsoId=P35125-2; Sequence=VSP_010878, VSP_010879;
CC       Name=3; Synonyms=210(ORF1), oncTre210p;
CC         IsoId=P35125-3; Sequence=VSP_010880, VSP_010881;
CC         Note=Was shown to be tumorigenic in transfected mice and seems
CC         not to act as GTPase activating protein.;
CC   -!- TISSUE SPECIFICITY: Testis specific. Expressed in various cancer
CC       cell lines. {ECO:0000269|PubMed:12604796,
CC       ECO:0000269|PubMed:1565468}.
CC   -!- DOMAIN: The Rab-GAP TBC domain lacks GTPase activator activity but
CC       is necessary for interaction with ARF6.
CC   -!- PTM: Monubiquitinated; ubiquitination is calmodulin and calcium
CC       dependent. {ECO:0000269|PubMed:16127172}.
CC   -!- DISEASE: Note=A chromosomal aberration involving USP6 is a common
CC       genetic feature of aneurysmal bone cyst, a benign osseous
CC       neoplasm. Translocation t(16;17)(q22;p13) with CDH11. The
CC       translocation generates a fusion gene in which the strong CDH11
CC       promoter is fused to the entire USP6 coding sequence, resulting in
CC       USP6 transcriptional up-regulation (PubMed:15026324).
CC       {ECO:0000269|PubMed:15026324}.
CC   -!- MISCELLANEOUS: The USP6 gene only exists in the primate lineage.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/USP6ID530ch17p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63546; CAA45108.1; -; mRNA.
DR   EMBL; X63547; CAA45111.1; -; mRNA.
DR   EMBL; AY143550; AAN38838.1; -; mRNA.
DR   EMBL; AY163314; AAO21348.1; -; Genomic_DNA.
DR   CCDS; CCDS11069.2; -. [P35125-1]
DR   PIR; S57867; S57867.
DR   PIR; S57868; S22158.
DR   PIR; S57874; S22155.
DR   RefSeq; NP_001291213.1; NM_001304284.1.
DR   RefSeq; NP_004496.2; NM_004505.3. [P35125-1]
DR   RefSeq; XP_011522352.1; XM_011524050.1. [P35125-1]
DR   RefSeq; XP_011522353.1; XM_011524051.2. [P35125-1]
DR   RefSeq; XP_011522354.1; XM_011524052.2. [P35125-1]
DR   RefSeq; XP_011522355.1; XM_011524053.2. [P35125-1]
DR   RefSeq; XP_011522356.1; XM_011524054.2. [P35125-1]
DR   RefSeq; XP_011522357.1; XM_011524055.2. [P35125-1]
DR   RefSeq; XP_011522358.1; XM_011524056.2. [P35125-1]
DR   RefSeq; XP_011522361.1; XM_011524059.2. [P35125-3]
DR   RefSeq; XP_016880779.1; XM_017025290.1. [P35125-1]
DR   UniGene; Hs.448851; -.
DR   ProteinModelPortal; P35125; -.
DR   SMR; P35125; -.
DR   BioGrid; 114552; 13.
DR   IntAct; P35125; 5.
DR   MINT; MINT-2865848; -.
DR   STRING; 9606.ENSP00000250066; -.
DR   MEROPS; C19.009; -.
DR   iPTMnet; P35125; -.
DR   PhosphoSitePlus; P35125; -.
DR   BioMuta; USP6; -.
DR   DMDM; 50403738; -.
DR   EPD; P35125; -.
DR   MaxQB; P35125; -.
DR   PaxDb; P35125; -.
DR   PeptideAtlas; P35125; -.
DR   PRIDE; P35125; -.
DR   DNASU; 9098; -.
DR   Ensembl; ENST00000250066; ENSP00000250066; ENSG00000129204. [P35125-1]
DR   Ensembl; ENST00000572949; ENSP00000461581; ENSG00000129204. [P35125-3]
DR   Ensembl; ENST00000574788; ENSP00000460380; ENSG00000129204. [P35125-1]
DR   GeneID; 9098; -.
DR   KEGG; hsa:9098; -.
DR   UCSC; uc002gau.2; human. [P35125-1]
DR   CTD; 9098; -.
DR   DisGeNET; 9098; -.
DR   GeneCards; USP6; -.
DR   H-InvDB; HIX0202554; -.
DR   HGNC; HGNC:12629; USP6.
DR   HPA; HPA046969; -.
DR   MIM; 604334; gene.
DR   neXtProt; NX_P35125; -.
DR   OpenTargets; ENSG00000129204; -.
DR   PharmGKB; PA37254; -.
DR   eggNOG; KOG1102; Eukaryota.
DR   eggNOG; KOG1870; Eukaryota.
DR   eggNOG; COG5210; LUCA.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00670000097750; -.
DR   HOGENOM; HOG000154762; -.
DR   InParanoid; P35125; -.
DR   KO; K11837; -.
DR   OMA; HDSNIKN; -.
DR   OrthoDB; EOG091G01VD; -.
DR   PhylomeDB; P35125; -.
DR   TreeFam; TF324190; -.
DR   SIGNOR; P35125; -.
DR   ChiTaRS; USP6; human.
DR   GeneWiki; USP6; -.
DR   GenomeRNAi; 9098; -.
DR   PRO; PR:P35125; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000129204; -.
DR   CleanEx; HS_USP6; -.
DR   ExpressionAtlas; P35125; baseline and differential.
DR   Genevisible; P35125; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IPI:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; TAS:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IBA:GO_Central.
DR   GO; GO:0003676; F:nucleic acid binding; TAS:ProtInc.
DR   GO; GO:0017137; F:Rab GTPase binding; IBA:GO_Central.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0090630; P:activation of GTPase activity; IBA:GO_Central.
DR   GO; GO:0006464; P:cellular protein modification process; NAS:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; IBA:GO_Central.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0031338; P:regulation of vesicle fusion; IBA:GO_Central.
DR   GO; GO:0060627; P:regulation of vesicle-mediated transport; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR000195; Rab-GTPase-TBC_dom.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00566; RabGAP-TBC; 1.
DR   Pfam; PF00443; UCH; 1.
DR   SMART; SM00164; TBC; 1.
DR   SUPFAM; SSF47923; SSF47923; 2.
DR   PROSITE; PS50086; TBC_RABGAP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Cell membrane;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Endosome;
KW   Hydrolase; Membrane; Polymorphism; Protease; Proto-oncogene;
KW   Reference proteome; Thiol protease; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1   1406       Ubiquitin carboxyl-terminal hydrolase 6.
FT                                /FTId=PRO_0000080625.
FT   DOMAIN      100    292       Rab-GAP TBC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00163}.
FT   DOMAIN      532   1369       USP.
FT   ACT_SITE    541    541       Nucleophile.
FT   ACT_SITE   1328   1328       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   VAR_SEQ       1    317       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1565468}.
FT                                /FTId=VSP_010878.
FT   VAR_SEQ     318    359       GLWARLRNQFFDTWAMNDDTVLKHLRASTKKLTRKQGDLPP
FT                                P -> MPQRLPHARQHTPLPLGSADYRRVVSVRPQGPHRDP
FT                                KDSRDA (in isoform 2).
FT                                {ECO:0000303|PubMed:1565468}.
FT                                /FTId=VSP_010879.
FT   VAR_SEQ     774    786       NFPQDNQKVQLSV -> ISPLHHLQMECSP (in
FT                                isoform 3). {ECO:0000303|PubMed:1565468}.
FT                                /FTId=VSP_010880.
FT   VAR_SEQ     787   1406       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:1565468}.
FT                                /FTId=VSP_010881.
FT   VARIANT     475    475       W -> R (in dbSNP:rs8073787).
FT                                {ECO:0000269|PubMed:1565468}.
FT                                /FTId=VAR_051522.
FT   VARIANT     525    525       V -> I (in dbSNP:rs2304449).
FT                                /FTId=VAR_059749.
FT   VARIANT     912    912       R -> Q (in dbSNP:rs9899177).
FT                                {ECO:0000269|PubMed:1565468}.
FT                                /FTId=VAR_051523.
FT   VARIANT    1330   1330       I -> V (in dbSNP:rs1053611).
FT                                /FTId=VAR_051524.
FT   MUTAGEN     150    150       T->R: Does not restore GAP activity in
FT                                yeast complementation assay.
FT                                {ECO:0000269|PubMed:14521938}.
FT   MUTAGEN     187    187       R->Q: Does not restore GAP activity in
FT                                yeast complementation assay.
FT                                {ECO:0000269|PubMed:14521938}.
FT   MUTAGEN     541    541       C->S: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:16127172}.
FT   CONFLICT    963    963       N -> I (in Ref. 1; CAA45111).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1406 AA;  158658 MW;  D3A6822CEB441DB3 CRC64;
     MDMVENADSL QAQERKDILM KYDKGHRAGL PEDKGPEPVG INSSIDRFGI LHETELPPVT
     AREAKKIRRE MTRTSKWMEM LGEWETYKHS SKLIDRVYKG IPMNIRGPVW SVLLNIQEIK
     LKNPGRYQIM KERGKRSSEH IHHIDLDVRT TLRNHVFFRD RYGAKQRELF YILLAYSEYN
     PEVGYCRDLS HITALFLLYL PEEDAFWALV QLLASERHSL PGFHSPNGGT VQGLQDQQEH
     VVPKSQPKTM WHQDKEGLCG QCASLGCLLR NLIDGISLGL TLRLWDVYLV EGEQVLMPIT
     SIALKVQQKR LMKTSRCGLW ARLRNQFFDT WAMNDDTVLK HLRASTKKLT RKQGDLPPPA
     KREQGSLAPR PVPASRGGKT LCKGYRQAPP GPPAQFQRPI CSASPPWASR FSTPCPGGAV
     REDTYPVGTQ GVPSLALAQG GPQGSWRFLE WKSMPRLPTD LDIGGPWFPH YDFEWSCWVR
     AISQEDQLAT CWQAEHCGEV HNKDMSWPEE MSFTANSSKI DRQKVPTEKG ATGLSNLGNT
     CFMNSSIQCV SNTQPLTQYF ISGRHLYELN RTNPIGMKGH MAKCYGDLVQ ELWSGTQKSV
     APLKLRRTIA KYAPKFDGFQ QQDSQELLAF LLDGLHEDLN RVHEKPYVEL KDSDGRPDWE
     VAAEAWDNHL RRNRSIIVDL FHGQLRSQVK CKTCGHISVR FDPFNFLSLP LPMDSYMDLE
     ITVIKLDGTT PVRYGLRLNM DEKYTGLKKQ LRDLCGLNSE QILLAEVHDS NIKNFPQDNQ
     KVQLSVSGFL CAFEIPVPSS PISASSPTQI DFSSSPSTNG MFTLTTNGDL PKPIFIPNGM
     PNTVVPCGTE KNFTNGMVNG HMPSLPDSPF TGYIIAVHRK MMRTELYFLS PQENRPSLFG
     MPLIVPCTVH TRKKDLYDAV WIQVSWLARP LPPQEASIHA QDRDNCMGYQ YPFTLRVVQK
     DGNSCAWCPQ YRFCRGCKID CGEDRAFIGN AYIAVDWHPT ALHLRYQTSQ ERVVDKHESV
     EQSRRAQAEP INLDSCLRAF TSEEELGESE MYYCSKCKTH CLATKKLDLW RLPPFLIIHL
     KRFQFVNDQW IKSQKIVRFL RESFDPSAFL VPRDPALCQH KPLTPQGDEL SKPRILAREV
     KKVDAQSSAG KEDMLLSKSP SSLSANISSS PKGSPSSSRK SGTSCPSSKN SSPNSSPRTL
     GRSKGRLRLP QIGSKNKPSS SKKNLDASKE NGAGQICELA DALSRGHMRG GSQPELVTPQ
     DHEVALANGF LYEHEACGNG CGDGYSNGQL GNHSEEDSTD DQREDTHIKP IYNLYAISCH
     SGILSGGHYI TYAKNPNCKW YCYNDSSCEE LHPDEIDTDS AYILFYEQQG IDYAQFLPKI
     DGKKMADTSS TDEDSESDYE KYSMLQ
//
